In addition, new biochemical dysfunctions and disease symptoms have been added to the canonical phenotypic spectrum related to MT-ATP6 variants, such as carboxylase deficiency [153] or recurrent infections and immunodeficiency [130]. This evidence concerns the gene MT-ATP6 and Immunodeficiency.